tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

ATTO-1091

product1 mentionslast seen Nov 9, 2026

Next-generation ATTOBODY-based trispecific antibody targeting TL1A, IL-23p19, and integrin α4β7 for inflammatory bowel disease.

Relationships 2

ATTO-1091

Relationship

Attovia Therapeutics, Inc.developsATTO-1091

97% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1